Skip to main content
Premium Trial:

Request an Annual Quote

Matthew Meyer and Noah Nasser

Counsyl has appointed Matthew Meyer as senior vice president of corporate development and Noah Nasser as vice president of women's health sales. Meyer joins Counsyl from CareDx, where he served as chief business officer. He is also an attorney who has worked at Pfizer, and as general counsel at Cerimon Pharmaceuticals and Draeger Medical Systems. Meyer has also held commercial roles at Allscripts and Novartis in Switzerland. Nasser joins Counsyl from AltheaDx, where he commercialized testing for pharmacogenetics. Prior to his post at AltheaDx, he served as the global sales leader for Verinata Health, an Illumina company. Before the acquisition of the company by Illumina in 2013, Nasser was Verinata's vice president of sales and market development.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.